Table 2.
Demographic and clinical characteristics of study cohort
| Variables | Benign biliary conditions (n = 5) | Cholangiocarcinoma (n = 3) | Pancreatic cancer (n = 10) | Primary sclerosing cholangitis (n = 6) |
|---|---|---|---|---|
| Age, mean (SD); years | 44.0 (13.7) | 78.0 (7.1) | 72.1 (8.2) | 59.8 (15.0) |
| Female/male (n) | 5/0 | 1/2 | 3/7 | 2/4 |
| Albumin, mean (SD); mg/dL | 3.3 (1.9) | 3.4 (0.7) | 3.3 (0.7) | 2.6 (2.0) |
| Bilirubin, mean (SD); mg/dL | 0.42 (0.41) | 1.3 (0.9) | 5.9 (6.4) | 1.1 (1.2) |
| AKP, mean (SD); U/L | 66.6 (37.0) | 161 (69.1) | 505.2 (296.7) | 224.3 (214.4) |
| AST, mean (SD); U/L | 26.8 (16.8) | 44.7 (23.1) | 94.1 (63.4) | 42.3 (39.7) |
| ALT, mean (SD); U/L | 28.2 (16.8) | 33.0 (4.9) | 136.7 (131.9) | 49.2 (45.8) |
| CA 19-9, mean (SD) | NA | 85.8 (61.7) | 2591.7 (1191.2) | 958 (817.3) |
AKP = alkaline phosphatase; AST = aspartate aminotransferase; ALT = alanine aminotransferase; NA = not available